Constipation and Nephrogenic systemic fibrosis

Summary:

Nephrogenic systemic fibrosis is found among people with Constipation, especially for people who are male, 50-59 old.

The study analyzes which people have Nephrogenic systemic fibrosis with Constipation. It is created by eHealthMe based on reports of 17 people who have Constipation from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Constipation?

Constipation is found to be associated with 3,004 drugs and 4,610 conditions by eHealthMe. Check the latest studies of Constipation.

What is Nephrogenic systemic fibrosis?

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease) is found to be associated with 512 drugs and 671 conditions by eHealthMe. Check the latest studies of Nephrogenic systemic fibrosis.



On Jul, 12, 2026

17 people who have Constipation and Nephrogenic Systemic Fibrosis are studied.

Would you have Nephrogenic systemic fibrosis when you have Constipation?

Gender of people who have Constipation and experienced Nephrogenic Systemic Fibrosis *:

  • female: 35.29 %
  • male: 64.71 %

Age of people who have Constipation and experienced Nephrogenic Systemic Fibrosis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 93.33 %
  • 60+: 6.67 %

Common co-existing conditions for these people *:

  1. Stress And Anxiety: 8 people, 47.06%
  2. Pain: 8 people, 47.06%
  3. Neoplasm Malignant (cancer tumour): 8 people, 47.06%
  4. Tumor: 8 people, 47.06%
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 29.41%
  6. Gastric Ulcer (stomach ulcer): 5 people, 29.41%
  7. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 5 people, 29.41%
  8. Nuclear Magnetic Resonance Imaging Brain: 4 people, 23.53%
  9. High Blood Pressure: 4 people, 23.53%
  10. Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 3 people, 17.65%

Common drugs taken by these people *:

  1. Magnevist: 16 people, 94.12%
  2. Omniscan: 13 people, 76.47%
  3. Capecitabine: 8 people, 47.06%
  4. Keppra: 8 people, 47.06%
  5. Miralax: 8 people, 47.06%
  6. Ativan: 8 people, 47.06%
  7. Plavix: 8 people, 47.06%
  8. Multihance: 8 people, 47.06%
  9. Ambien: 8 people, 47.06%
  10. Gemcitabine: 6 people, 35.29%

Common symptoms for these people *:

  1. Renal Cell Carcinoma (a kidney cancer): 8 people, 47.06%
  2. Stress And Anxiety: 6 people, 35.29%
  3. Mobility Decreased (ability to move is reduced): 6 people, 35.29%
  4. Oedema Peripheral (superficial swelling): 6 people, 35.29%
  5. Skin Fibrosis (fibrous tissue formation on skin): 6 people, 35.29%
  6. Pain: 6 people, 35.29%
  7. Skin Disorder (skin disease): 6 people, 35.29%
  8. Arthropathy: 5 people, 29.41%
  9. Cardiac Disorder: 5 people, 29.41%
  10. Dyspnea (difficult or laboured breathing): 5 people, 29.41%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Nephrogenic systemic fibrosis?

- Check whether Nephrogenic systemic fibrosis is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Nephrogenic systemic fibrosis:

All the conditions that are associated with Nephrogenic systemic fibrosis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Nephrogenic systemic fibrosis and Constipation, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: